Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 10/20 | 0.69 |
| ▸ | SHBG | P04278 | 7/20 | 0.51 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.43 |
| ▸ | PGR | P06401 | 4/20 | 0.41 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7112542 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL12355430 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL6012294 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL6012356 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL24103283 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL12364347 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL24102490 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL24102641 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL24103277 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 | |
| SCHEMBL2246608 | 1.00 | AR (0.69) | ARSHBGSLC22A1ALDH1A1SERPINA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4164743-A2 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2023-04-19 | — | — | EP | disclosed |